JLE

European Journal of Dermatology

MENU

Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma Volume 29, numéro 6, November-December 2019

Figure 1

Magnetic resonance imaging of Patient 4 before treatment (A) showing bone and leptomeningeal invasion, and three months after treatment (B) showing an impressive partial response.

Figure 2

Patient 2 before treatment (A) showing an unresectable retro-auricular mass (lymph node involvement), and after three months of treatment (B).